ArTS Archivio della ricerca di Trieste

SOBHANI, NAVID
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.727
EU - Europa 2.270
AS - Asia 1.821
SA - Sud America 216
Continente sconosciuto - Info sul continente non disponibili 163
AF - Africa 54
OC - Oceania 9
Totale 8.260
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.658
PL - Polonia 850
SG - Singapore 665
IT - Italia 465
CN - Cina 457
SE - Svezia 212
HK - Hong Kong 186
BR - Brasile 167
VN - Vietnam 160
DE - Germania 140
KR - Corea 93
IE - Irlanda 90
FR - Francia 84
GB - Regno Unito 81
RU - Federazione Russa 71
NL - Olanda 65
FI - Finlandia 61
IN - India 49
CA - Canada 42
BD - Bangladesh 39
UA - Ucraina 31
TR - Turchia 28
BG - Bulgaria 25
MA - Marocco 22
AR - Argentina 21
JP - Giappone 18
MY - Malesia 18
ES - Italia 14
AT - Austria 13
MX - Messico 13
PK - Pakistan 13
BE - Belgio 12
ZA - Sudafrica 12
IQ - Iraq 11
IR - Iran 11
ID - Indonesia 10
SA - Arabia Saudita 10
CH - Svizzera 8
CZ - Repubblica Ceca 7
JO - Giordania 7
RO - Romania 7
UZ - Uzbekistan 7
DZ - Algeria 6
EC - Ecuador 6
PH - Filippine 6
VE - Venezuela 6
MD - Moldavia 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
CL - Cile 4
CR - Costa Rica 4
IL - Israele 4
LT - Lituania 4
NP - Nepal 4
OM - Oman 4
PY - Paraguay 4
AL - Albania 3
AO - Angola 3
AU - Australia 3
CO - Colombia 3
EE - Estonia 3
HU - Ungheria 3
KE - Kenya 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PS - Palestinian Territory 2
SI - Slovenia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 8.094
Salva come PNG Salva come JPEG
Città #
Warsaw 817
Ashburn 458
Singapore 409
Fairfield 354
Chandler 214
Houston 201
San Jose 196
Hong Kong 180
Woodbridge 173
Seattle 142
Trieste 131
Ann Arbor 118
Cambridge 115
Wilmington 108
Beijing 104
Council Bluffs 104
Menlo Park 88
Santa Clara 87
Seoul 86
Hefei 80
Columbus 71
Dallas 66
Boardman 63
Los Angeles 53
Princeton 50
Chicago 47
Ho Chi Minh City 44
Helsinki 39
Lauterbourg 39
Jacksonville 38
Milan 36
Munich 35
New York 35
Moscow 32
Frankfurt am Main 31
Dublin 30
The Dalles 26
Hanoi 25
Zgierz 25
Sofia 24
Phoenix 23
Dearborn 22
Dong Ket 22
Buffalo 20
London 19
Orem 19
Redwood City 19
Izmir 18
Atlanta 17
Bremen 17
São Paulo 17
San Diego 16
Poplar 15
Casablanca 14
Denver 14
Duino-Aurisina 14
Toronto 14
Rome 13
Nuremberg 12
Shanghai 12
Tokyo 12
Amsterdam 11
Montegaldella 11
Boston 10
Brussels 10
Hangzhou 10
Tianjin 10
Turku 10
Da Nang 9
Lappeenranta 9
Chennai 8
Guangzhou 8
Johannesburg 8
Memphis 8
Mumbai 8
Nanjing 8
Redondo Beach 8
Udine 8
Amman 7
Brasília 7
Decatur 7
Eagan 7
Genoa 7
Montreal 7
Redmond 7
Tehran 7
Brooklyn 6
Düsseldorf 6
Florence 6
Kunming 6
Norwalk 6
Paris 6
Portsmouth 6
Rio de Janeiro 6
Tashkent 6
Vienna 6
Belo Horizonte 5
Birmingham 5
Cagliari 5
Changsha 5
Totale 5.613
Salva come PNG Salva come JPEG
Nome #
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 461
Advances in systemic therapy for metastatic breast cancer: future perspectives 430
The predictive role of the immune system for response to therapy and survival in patients with solid tumors. 419
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 404
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 372
Bevacizumab in small cell lung cancer 353
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 343
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 314
Corticosteroid switch after progression on abiraterone acetate plus prednisone 311
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 294
Advances in systemic therapy for malignant mesothelioma: Future perspectives 283
Lenvatinib for the treatment of renal cell carcinoma 273
PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy 269
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 258
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 249
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5) 223
Analysis of PD-L1 and CD3 Expression in Glioblastoma Patients and Correlation with Outcome: A Single Center Report 207
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 201
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 190
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy 185
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses 175
Avelumab in gastric cancer 159
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair 158
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 153
Mutant p53 as an antigen in cancer immunotherapy 143
Updates on the CDK4/6 inhibitory strategy and combinations in breast cancer 134
Early changes of the standardized uptake values (SUVmax) predict the efficacy of everolimus-exemestane in patients with hormone receptor-positive metastatic breast cancer 125
Cancer management during the COVID-19 world pandemic 125
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 122
Cancer/testis antigens: from serology to mRNA cancer vaccine 120
Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials 110
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer 103
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2- Breast Cancer Based on a Window of Opportunity Study 98
Current Trends in Liquid Biopsy Tracking Resistance in Molecular Breast Cancer-Targeted Therapies 93
Immune-gene signature: A new tool for patient selection for checkpoint inhibitors? 90
P53 antibodies as a diagnostic marker for cancer: A meta-analysis 85
Predictive and Prognostic Value of Non-Coding RNA in Breast Cancer 83
The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study 76
The fibroblast growth factor receptors in breast cancer: From oncogenesis to better treatments 69
Totale 8.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022375 0 0 43 37 10 38 26 14 53 61 17 76
2022/2023598 58 100 77 77 50 79 4 62 51 10 21 9
2023/2024530 13 67 57 45 33 43 103 84 2 26 31 26
2024/20251.278 13 123 186 95 97 118 68 56 156 141 104 121
2025/20262.427 239 150 149 287 235 206 305 83 209 336 142 86
2026/2027268 79 113 76 0 0 0 0 0 0 0 0 0
Totale 8.260